Abstract:Objective To analyze and compare the physical and chemical characterizations of human serum albumin/interferon alpha-2a fusion protein and human serum albumin/interferon alpha-2b fusion protein drugs.Methods The genetically engineered yeast Pichia pastoris strains used in the expression of rHSA/IFNα2a or rHSA/IFNα2b fusion proteins were constructed separately.The fusion protein was directly secreted by yeast into a simple non-organic culture medium,then purified by three-step highly-efficient chromatography.The physical and chemical characterizations of the highly purified drug-level fusion proteins were investigated in detail.Results Characterization analysis results from the two fusion proteins were obtained including protein purity,which is more than 98%.The first 15 amino acids of the N-terminal sequence of the fusion protein match that of the predicted sequence,with the molecular mass of Maldi-TOF/TOF spectrum being 85788.4D and 85706.1D for rHSA/IFNα2a and rHSA/IFNα2b,respectively.UV-circular dichroism(CD) spectra is not different compared with HSA or interferon-α,and fusion protein's IEF(pI) is around 5.1.The fusion proteins are non-glycoprotein with staining,and UV-wavelength specification shows typical protein spectroscopy.Measurement of free-sulfhydryl(SH) group matchs the predicted value;and mass spectrometric peptide mapping shows 83% or 82% identity to the predicted peptide fragments,respectively.The residues in the bulk preparations are also investigated and meet the standard requirement,including the endotoxin,host protein,exogenous DNA,methanol and glycerol.The immune-identification is positive and the anti-virus bio-assay in vitro is 2.5 × 105 IU/mg,with no difference seen between two fusion proteins.Conclusions The methods used and results obtained from this study may be used as qualification standards in making the clinically available final products of long acting interferon-α protein drugs,Recombinant human serum albumin/interferona2a fusion protein for injection and recombinant human serum albumin/interferona2b fusion protein for injection.

Expression and the physical and chemical characterizations studies of recombinant human serum albumin/granulocyte colony-stimulating factor fusion protein with long-acting bio-function

Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia Pastoris.

Expression and the Physical and Chemical Characterizations Studies of Two Recombinant Human Serum Albumin/interferon-Α(2a;2b) Fusion Proteins with Long-Acting Bio-Function

Engineering a Pharmacologically Superior Form of Granulocyte-Colony-stimulating Factor by Fusion with Gelatin-Like-protein Polymer.

High Level Expression and Purification of Recombinant Human Serum Albumin in Pichia Pastoris.

Engineering of a Pichia pastoris Expression System for High-Level Secretion of HSA/GH Fusion Protein

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-α2b fusion protein expressed in Pichia pastoris

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique

Expression and Purification of Recombinant Human Serum Albumin from Selectively Terminable Transgenic Rice

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].

Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon α1 fusion protein expressed in Pichia pastoris

Expression, purification, and characterization of the active immunoglobulin-like domain of human granulocyte-colony-stimulating factor receptor in Escherichia coli

Expression of Human Globular Adiponectin-Glucagon-like Peptide-1 Analog Fusion Protein and Its Assay of Glucose-Lowering Effect in Vivo.

Preparation and Characterization of Site-Specific Fatty Chain-Modified Recombinant Human Granulocyte Colony Stimulating Factor

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity

The Effect of Gene Copy Number and Co-Expression of Chaperone on Production of Albumin Fusion Proteins in Pichia Pastoris.

Pharmacokinetics of PEG-rhG-CSF and rHSA-hG-CSF in mice determined with ELISA

Medium Optimization for High Yield Production of Human Serum Albumin in Pichia Pastoris and Its Efficient Purification

The Expression of Recombinant Human Serum Albumin in the Mammary Gland of Transgenic Mice